Medical Marijuana, Inc. Announces Historic Registration of its CBD Products in Paraguay as a Medicine


?Medical Marijuana, Inc.?(OTC: MJNA), the first publicly traded cannabis company in?the United States, today announced the historic registration of its?Real Scientific Hemp Oil-X? (RSHO-X?)?and RSHO?-Blue Label CBD products as registered medicines by?Paraguay’s?national health regulation organization (Direcci?n Nacional de Vigilancia Sanitaria).

“We are a Company of firsts and we are excited about this new historic milestone of being the first company to have a CBD product registered in?Paraguay,” said Medical Marijuana, Inc. CEO Dr.?Stuart Titus.

“We have actively pursued getting our pipeline of botanical cannabis products registered and approved as therapeutic products in countries around the world, which opens the ability for international pharmacies and healthcare providers to distribute cannabis products to patients,” added Dr. Titus. “This is yet another example of the international trend of acceptance of CBD for therapeutic use, and we are continually encouraged by the decisions of governments and regulators to permit use of cannabis and CBD products for patients?suffering from multiple indications – especially where conventional medicine has had modest or?limited effects.”

Paraguay’s?official registration of Medical Marijuana, Inc.’s CBD hemp oil products marks the first country that has registered and approved the Company’s products as medicinal products. Currently, Medical Marijuana, Inc.’s CBD hemp oil products have been used in?Paraguay?with medical indications ranging from cancer, pain, multiple sclerosis, epilepsy and various other neurological diseases.

Prior to becoming registered as official medicines, in May of 2016, Real Scientific Hemp Oil? became the first medical cannabis product approved and imported for use in?Paraguay?for compassionate?use with a prescription and government permission. This event marked the third time in a little over a year that RSHO? was the first cannabis product approved in a Latin American country, following the lead of?Brazil?and?Mexico.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: